Roth Michaela, Carlsson Robert, Buizza Carolina, Enström Andreas, Paul Gesine
Translational Neurology Group, Department of Clinical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden.
Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
J Cereb Blood Flow Metab. 2025 Apr;45(4):617-629. doi: 10.1177/0271678X241261946. Epub 2024 Jul 25.
Stroke is one of the leading causes of death and disability, yet the cellular response to the ischemic insult is poorly understood limiting therapeutic options. Brain pericytes are crucial for maintaining blood-brain barrier (BBB) integrity and are known to be one of the first responders to ischemic stroke. The exact timeline of cellular events after stroke, however, remains elusive. Using the permanent middle cerebral artery occlusion stroke model, we established a detailed timeline of microvascular events after experimental stroke. Our results show that pericytes respond already within 1 hour after the ischemic insult. We find that approximately 30% of the pericyte population dies as early as 1 hour after stroke, while ca 50% express markers that indicate activation. A decrease of endothelial tight junctions, signs of endothelial cell death and reduction in blood vessel length are only detected at time points after the initial pericyte response. Consistently, markers of BBB leakage are observed several hours after pericyte cell death and/or vascular detachment. Our results suggest that the pericyte response to stroke occurs early and precedes both the endothelial response and the BBB breakdown. This highlights pericytes as an important target cell type to develop new diagnostic and therapeutic tools.
中风是导致死亡和残疾的主要原因之一,然而,细胞对缺血性损伤的反应却知之甚少,这限制了治疗选择。脑周细胞对于维持血脑屏障(BBB)的完整性至关重要,并且已知是缺血性中风的首批反应细胞之一。然而,中风后细胞事件的确切时间线仍然难以捉摸。利用永久性大脑中动脉闭塞性中风模型,我们建立了实验性中风后微血管事件的详细时间线。我们的结果表明,周细胞在缺血性损伤后1小时内就会做出反应。我们发现,早在中风后1小时,约30%的周细胞群体死亡,而约50%表达表明激活的标志物。内皮紧密连接减少、内皮细胞死亡迹象和血管长度缩短仅在最初的周细胞反应后的时间点才被检测到。一致地,在周细胞死亡和/或血管脱离数小时后观察到血脑屏障渗漏的标志物。我们的结果表明,周细胞对中风的反应发生得很早,且先于内皮反应和血脑屏障破坏。这突出了周细胞作为开发新的诊断和治疗工具的重要靶细胞类型。